Advanced search

News (254)

DOJ's First 10b5-1 Plan Prosecution Survives Motion To Dismiss	Mar. 19	AQ
Ontrak Announces 2023 Second Quarter Financial Results	23-08-09	BU
MOORE KUEHN ENCOURAGES ONTRAK, INC. INVESTORS TO CONTACT LAW FIRM	23-07-20	PR
Rule 10b5-1 Application And Enforcement	23-05-26	AQ
Ontrak Announces 2023 First Quarter Financial Results	23-05-10	BU
Transcript : EVmo, Inc., 2022 Earnings Call, Apr 19, 2023	23-04-19
ONTRAK, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-04-17	AQ
On Heels Of Recent Rule Amendments, DOJ And SEC Target Purported 10b5-1 Trading Plan Abuse	23-03-22	AQ
DOJ And SEC Used Data Analytics To Target Insider Trading With 10b5-1 Plans	23-03-22	AQ
Landmark SEC And DOJ Insider Trading Cases Signal Increased Scrutiny Of Rule 10b5-1 Plans	23-03-21	AQ
Transcript : Ontrak, Inc., Q4 2022 Earnings Call, Mar 15, 2023	23-03-15
Ontrak Announces 2022 Fourth Quarter and Year End Financial Results	23-03-15	BU
BioVie : Management Change - Form 8-K	23-03-06	PU
BIOVIE INC. : Change in Directors or Principal Officers (form 8-K)	23-03-06	AQ
BioVie Inc. Announces Executive Changes	23-03-06	CI
Ontrak CEO Peizer resigns after being charged for insider trading	23-03-03	RE
Ontrak CEO Peizer resigns	23-03-03	RE
ONTRAK, INC. : Change in Directors or Principal Officers, Other Events (form 8-K)	23-03-03	AQ
Ontrak, Inc. Announces Executive Changes	23-03-03	CI
Ontrak, Inc. Announces Management Changes	23-03-03	CI
SEC Charges Ontrak Chairman Terren Peizer with Insider Trading	23-03-02	AQ
Ontrak Health CEO indicted for alleged insider trading	23-03-01	AQ
US authorities charge healthcare company Ontrak's boss with insider trading	23-03-01	RE
EVMO, INC. Other Events (form 8-K/A)	23-02-28	AQ
Transcript : Ontrak, Inc. - Shareholder/Analyst Call	23-02-20
EVMO, INC. : Other Events (form 8-K)	23-02-17	AQ
EVMO, INC. : Change in Directors or Principal Officers (form 8-K)	23-02-17	AQ
Evmo, Inc. Announces Board Changes	23-02-17	CI
ONTRAK, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-11-21	AQ
BIOVIE INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	22-11-10	AQ
Transcript : Ontrak, Inc., Q3 2022 Earnings Call, Nov 09, 2022	22-11-09
•Company pays off in full its $7.5 million outstanding GS loan balance; draws down a total of $11 million to date on the Keep Well Agreement •Company raises $3.3 million, net, in a registered direct offering of shares of Company's common stock with institutional investors •Company notes progress in sales prospect pipeline, including two plans in finalization of MSA and SOW phase •Company to Host Conference Call at 4:30 pm ET Today - Form 8-K	22-11-09	PU
Ontrak Announces 2022 Third Quarter Financial Results	22-11-09	BU
EVMO, INC. : Other Events (form 8-K)	22-10-06	AQ
ONTRAK, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	22-09-09	AQ
ONTRAK, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	22-08-31	AQ
Ontrak Names James Messina to its Board of Directors	22-08-30	BU
Transcript : Ontrak, Inc. - Shareholder/Analyst Call	22-08-29
Transcript : Ontrak, Inc., Q2 2022 Earnings Call, Aug 09, 2022	22-08-09
Ontrak Announces 2022 Second Quarter Financial Results	22-08-09	BU
•Company pays off in full its $19.2 million outstanding loan balance; draws down $5.0 million on Keep Well Agreement •Company raises $3.5 million, net, in a registered direct offering of shares of Company's common stock with institutional investors •Company enters into partnership with Eleos on AI integration •Company notes progress in sales prospect pipeline, including multiple plans in data exchange phase •Company to Host Conference Call at 4:30 pm ET Today - Form 8-K	22-08-09	PU
ONTRAK, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-08-09	AQ
Ontrak Announces Closing of Registered Direct Offering for Aggregate Gross Proceeds of $4.0 Million	22-08-04	BU
Ontrak : Announces Registered Direct Offering for Aggregate Gross Proceeds of $4.0 Million Priced At-The-Market Under Nasdaq Rules - Form 8-K	22-08-04	PU
Ontrak Announces Registered Direct Offering for Aggregate Gross Proceeds of $4.0 Million Priced At-The-Market Under Nasdaq Rules	22-08-02	BU

1234NextSee all

Insiders

Terren Peizer

Mr. Terren S. Peizer is an Executive Chairman at YayYo, Inc., a Chairman at BioVie, Inc., a Managing Director at Socius Capital Partners LLC, a Chairman at Xcorporeal Operations, Inc., a Chairman at Acuitas Group Holdings LLC, an Executive Chairman at Ontrak, Inc., a Chairman at Crede Capital Group LLC, a Chairman & Chief Executive Officer at NeurMedix, Inc. and a Chief Executive Officer at Intellect Capital Ventures LLC. He is on the Board of Directors at Adaptive Holdings Ltd. and CasperLabs Networks AG. Mr. Peizer was previously employed as a Chairman by Cray, Inc., a Vice Chairman & President by Harbor BioSciences, Inc., and an Owner by Acuitas Capital Group, LLC. He also served on the board at Xcorporeal, Inc. and Clearant, Inc. He received his undergraduate degree from The Wharton School of the University of Pennsylvania.

François Terren is currently working as a Product Manager at Baxter SAS.
Prior to this, he worked as a Director at Mobile Distillery SA. He also served as the Chief Investment Officer at SCOR SA (Investment Management) from 2003 to 2005.

No results for this search